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Introduction: Fibroadenomas (FADs) are benign breast lesions usually seen in late teens less so common
in postmenopausal women. This is a case series of postmenopausal patients, where breast cancer looked
like ﬁbroadenoma on imaging. The aim of this study was to identify the important role of tissue diagnosis
in FAD like lesions on imaging and highlight the deceiving imaging ﬁndings.
Materials and methods: We retrospectively reviewed the medical records of patients at our Breast unit
who were treated for breast cancer under one surgeon in the period of Feb 2009 to Jan 2010. Patients
underwent triple assessment as per protocol of the breast screening unit. All had ﬁne needle aspiration
and core biopsy of the lesions. Appropriate surgery was offered and the size, grade and lymph node
status were evaluated and Nottingham Prognostic Index (NPI) used to predict survival.
Results: 5 patients were identiﬁed with breast cancers that had initial radiological diagnosis of ﬁbroa-
denoma. All patient lesions were screen detected on NHS screening programme. One patient out of ﬁve
was discharged after triple assessment and represented with a lump 18 months later. The Median age
was 56 years (range 50e66 years). The mammogram showed these to be benign-looking lesions and
ultrasound scans suggested ﬁbroadenomas as reported by specialist breast radiologist. Seven lesions
were identiﬁed in 5 patients. One patient had 3 lesions. Lesions size ranged between 8 mm and 25 mm
on mammogram (median 14 mm) and 8e20 mm on ultrasound (range 8e20). Fine needle aspiration
cytology was C5 in the two lesions, C4 in 2 and C3 in 1 lesion. Two patients had unifocal grade 3 tumours.
One patient had multifocal cancer (3 cancers e in unilateral breast) all were grade 3 cancers with lymph
node involvement. One patient had grade 2 cancer and 1 was found to have adenoid cystic adenocar-
cinoma and therefore the grade and NPI were not assessed. NPI was good in 1, moderate in 2 and poor in
1 patient.
Conclusion: Our case series suggested that one should have a high index of suspicion for FAD in the
postmenopausal ladies and triple assessment should include thorough tissue sampling in the form of
FNA and core biopsy.
 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Fibroadenoma is the most common breast tumor in adolescent
girls and women younger than 25 years but less so in post-
menopausal women. Triple assessment i.e. clinical examination,
imaging and tissue sampling is currently the gold standard1 for
assessingnewbreast lesions inUK. Some lesions detectedon imaging
are interpreted as having a very low probability of malignancy2and
several studies3e5 have been performed to highlight the importance
of mammographic or sonographic surveillance as opposed to ﬁne
needle biopsy or core biopsies. Rosen et al. (2002) suggested that
short-term mammographic follow-up is recommended for lesions
that, in retrospect, do not fulﬁll established diagnostic criteria forciates Ltd. Published by Elsevier Ltprobably benign lesions. This approach permitted identiﬁcation of
a few low-stage carcinomas (Vizcaíno et al., 2001). Since Fibroade-
noma is not common in postmenopausal women, there should be
a high suspicion of index for all FAD like lesions and the question or
difﬁculty in these groups of patients is whether to undertake biopsy
or follow-up for surveillance imaging. These should undergo biopsy
and not left for surveillance imaging.
Our study was a retrospective small case series of 5 patients,
where initial imaging suggested FAD but later FNAC/Core biopsy
conﬁrmed ca.
2. Materials and methods
We retrospectively reviewed the notes of all patients with breast cancers
referred to one breast surgeon practice between Feb 2009 and Jan 2010. All patients
had bilateral mammogram obtained in mediolateral and craniocaudal projections.
This was evaluated by a specialist consultant breast radiologist. This was followed by
ultrasound of whole breast by the same radiologist and ﬁndings were documentedd. All rights reserved.
Table 1
RAD scoring.
Category Diagnosis
M1/U1 Negative
M2/U2 Benign
M3/U3 Probably Benign
M4/U4 Highly Suspicious of Malignancy
M5/U5 Malignant Features
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5 (U1/M1 ¼ Normal, U2/M2 ¼ probably benign lesion, U3/M3 ¼ an abnormality
present of indeterminate signiﬁcance, U4/M4 ¼ features suspicious of malignancy,
U5/M5 ¼ malignant). The radiological scoring (RAD) system was used for inter-
pretation of mammogram (see Table 1).
As per protocol patients had ﬁne needle aspiration FNA and core biopsy of the
lesions when FNA was C3 or above. FNA was graded as C1 Inadequate for diagnosis,
C2 Benign epithelial cells, C3 Atypia probably benign, C4 Suspicious of malignancy
and C5 Malignant. Similarly core biopsy of the lesion was graded B1 Unsatisfactory/
Normal breast tissue, B2 Benign, B3 Benign but of uncertain malignant potential, B4
Suspicious of malignancy and B5 Malignant.
After conﬁrmation of cancer these mammograms and ultrasound were double
read by a second specialist breast radiologist. After appropriate surgery the size,
type, grade and lymph node involvement were reviewed and the Nottingham
Prognostic Index (NPI)1 was used to predict survival broadly classiﬁed into excellent
2.24, good <2.4e3.4, moderate<3.4e4.4 and poor >5.
3. Results
135 patients were diagnosed with breast cancer in the period
between Feb2009 and Jan2010. Five patientswithbreast cancerhad
initial imaging that suggested ﬁbroadenoma as shown in Table 2.
The age range of the ﬁve patients was 50e66 years withmedian age
of 62 years. Four of these patients had recent screening showing the
new lesions which was impalpable. One lady (patient D) presented
with lump which was identiﬁed on a previous routine screening 18
months agowhen it was impalpable and diagnosed as FAD on triple
assessment.Table 2
Mammogram and ultrasound scan.
Age Screening Mamm Size
mm
U/S Size
mm
RAD U/
M1-5
Patient
A
50 1st Mass 25 FAD 20 U/M2
Patient
B
62 4th Mass 10 FAD 17 U/M3
Patient
C
50 1st MCL 16,9,9 FADx3 17,8,8 U/M3
Patient
Da
66 Diagnosed FAD on
previous screening
Mass 22 FAD 20 U/M3
Patient
E
66 5th Mass 8 FAD 9 U/M2
Mamm e Mammogram, U/S e Ultrasound, RAD e Radiological scoring,
FAD e Fibroadenoma.
a Patient presented with lump.
Table 3
Case series of four patients: FNA, Core biopsy and ﬁnal histology.
No No. of lesions FNA Core Histology Size
1e5 B5aec
1 1 C4 B5b Ductal 30
2 1 C3 B5b Adenoid cystic adenoca 18
3 1 C5 B5b Ductal 11
4 3 C5 B5b Ductal 17
C4 B5b Ductal 7
n/p n/p Ductal 8
5 1 C4 B5b Ductal 6
*Lymph node involved: Node negative ¼ 1, 1 ¼ 3 Positive nodes ¼ 2, >3 Positive nodesSeven lesions were diagnosed in 5 patients. Lesions size ranged
between 8 mm and 25 mm on mammogram (median 14 mm) and
8e20 mm on ultrasound (median 14 mm) as shown in Table 2.
The ﬁnal histology and NPI are listed in Table 3.
Median size on histology was 13.86 mm with a range of
6e30 mm. Three patients were found to be grade 3 cancers. The
lady with the lump was found to have adenoid cystic adenocarci-
noma and grading was not performed. Further breakup is shown in
Table 3.
4. Discussion
In this case series, the ﬁve postmenopausal patients had initial
imaging diagnosis suggesting FAD. All these patients underwent
adequate tissue sampling as per our practice and were then diag-
nosed with breast cancers.
Fibroadenoma constitutes 20% of the benign masses and 12% of
all breast masses in postmenopausal women.6 In UK the gold
standard is to perform triple assessment for newly diagnosed breast
but the use of short-term follow-up by either ultrasound or
mammogram is also recommended in several studies all over the
world. The rational for surveillance is multifactorial, besides high
negative predictive value of imaging, cancer is easily detected on
new changes on imaging and the cancer found is usually low grade
and therefore biopsies can be deferred as it increases the stress level
of patients. Studies claim that women who accept management by
periodic surveillance have signiﬁcantly (P < 0.001) lower levels of
stress than those who undergo core biopsy for benign lesions.7
The classical appearance of ﬁbroadenoma on ultrasound is
ellipsoid lesions with smooth surface and homogenously echogenic
with an NPV of 99%.4,8 Several studies have shown the importance
of short-term imaging surveillance for probably benign lesions and
that cancer can be detected if any changes seen.2,4 In a study by
Skaane et al. 1998 the NPV was 96% for non palpable lesion and
100% for palpable lesions on ultrasound.9 Although some believe
that FAD can be differentiated from cancers using ultrasound this
has never been proved in a proper prospective fashion.10 The
incidence of cancer is less than 2%2,3and is at early stage. Studies by
Victor E Bovbjerg et al.5and Sickle11 verify this and showed that the
malignancy has the same good prognosis as that of other cancers
diagnosed at screening. Contrarily Soo et al.2 had shown that 8
malignancies (16%) were stage II (3 were T2N1M0 [1, 4 and 5
positive lymph node] and 5 were T2N0M0), carrying a worse
prognosis. Our case series has shown similar results and out of 5
patients 3 of them had grade 3 cancer (one had axillary metastasis).
The NPI was poor in one and moderate in 2 and good in only 1 lady.
It was not assessed in the patient with adenoid cystic adenocarci-
noma which is a very rare cancer of the breast usually found in the
parotid glands.
Wait and watch policy with follow-up scan not only provides
temporary false reassurance but may worsen the prognosis. Not to
forget the medico legal implication of delay in diagnosing breastmm Grade 1e3 Lymph node involved 1e3 NPI Prognosis
3 1 4.06 Moderate
n/a 1 n/a n/a
3 1 4.22 Moderate
3 3 6.34 Poor
3
3
2 1 3.12 Good
¼ 3 *n/p not performed, N/A not assessed.
H. Khout et al. / International Journal of Surgery 9 (2011) 2e44cancer dictating that conservative management can only be offered
to patients whose ﬁbroadenoma has been diagnosed with the triple
test.12
We therefore conclude that any solid lesion that appears de
novo in older females should be considered suspicious and not
dismissed as a FAD and not left for surveillance imaging without
adequate tissue sample.
We recognize the limitation of our study because of the small
number of patients. Further studies are needed to formalize aworld-
wide protocol for benign-looking lesions in postmenopausal ladies.
5. Conclusion
In this case series, we conclude that any solid lesion that appears
de novo in postmenopausal females should be considered suspi-
cious and not dismissed as a FAD. We believe that these lesions
should not be left for surveillance imaging without adequate tissue
sample. Our study emphasizes on the importance of triple assess-
ment in Breast Cancer.
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